NRCME Endocrine and Metabolic Conditions 2 — Questions and Answers
Question 1: A driver with well-controlled gout reports no acute episodes in the past year and takes allopurinol daily. What certification decision is appropriate?
- Disqualify due to joint disease
- Certify if no functional impairment affecting vehicle operation (Correct answer)
- Certify for 6 months pending re-evaluation
- Require rheumatology clearance
Correct answer: Certify if no functional impairment affecting vehicle operation
Well-controlled gout with no functional impairment affecting the driver's ability to safely operate a vehicle does not preclude medical certification.
Question 2: Cushing's syndrome in a commercial driver may affect certification primarily due to which associated condition?
- Chronic sinusitis
- Secondary hypertension, diabetes, and muscle weakness (Correct answer)
- Skin pigmentation changes
- Increased appetite alone
Correct answer: Secondary hypertension, diabetes, and muscle weakness
Cushing's syndrome commonly causes secondary hypertension, steroid-induced diabetes, and proximal muscle weakness — all of which can independently affect driver qualification.
Question 3: What is the primary reason the FMCSA requires CMEs to evaluate thyroid status during the DOT physical?
- To screen for cancer
- To identify conditions causing fatigue, arrhythmia, or impaired cognition affecting driving safety (Correct answer)
- To check dietary iodine levels
- To comply with endocrine screening mandates
Correct answer: To identify conditions causing fatigue, arrhythmia, or impaired cognition affecting driving safety
Thyroid disorders can cause fatigue, cardiac arrhythmias, and cognitive impairment that directly affect a driver's ability to safely operate a commercial vehicle.
Question 4: A driver with metabolic syndrome presents with controlled hypertension, borderline glucose, and central obesity. What should the CME do?
- Disqualify due to metabolic syndrome diagnosis
- Assess each component individually against FMCSA standards and certify accordingly (Correct answer)
- Issue only a 6-month certificate regardless
- Refer to a cardiologist before any decision
Correct answer: Assess each component individually against FMCSA standards and certify accordingly
The CME must evaluate each component of metabolic syndrome independently against FMCSA standards, as the syndrome itself is not a disqualifying diagnosis.
Question 5: A driver reports a history of thyroid cancer with surgical removal and is currently euthyroid on thyroid hormone replacement. How should the CME proceed?
- Disqualify permanently due to cancer history
- Certify if currently euthyroid with no recurrence or disqualifying side effects (Correct answer)
- Require oncologist clearance annually
- Issue a 3-month temporary certificate only
Correct answer: Certify if currently euthyroid with no recurrence or disqualifying side effects
A driver with a history of thyroid cancer who is currently euthyroid on replacement therapy and has no recurrence or disqualifying complications may be certified.
Question 6: Which type of medication commonly used to treat type 2 diabetes carries the lowest risk of hypoglycemia and is therefore least likely to create a safety concern for commercial drivers?
- Sulfonylureas
- Insulin glargine
- Metformin (Correct answer)
- Glipizide
Correct answer: Metformin
Metformin works by reducing hepatic glucose production and does not stimulate insulin secretion, giving it a very low risk of causing hypoglycemia compared to insulin secretagogues.
NRCME Endocrine and Metabolic Conditions 2
A driver with well-controlled gout reports no acute episodes in the past year and takes allopurinol daily.
What certification decision is appropriate?